Minoxidil 2% vs minoxidil 5%
Change in quality of life · women with FPHL
1 finding from 1 review
- no estimate extracted1 study · 209 participantsLow
Findings
What do systematic reviews say?
169 questions · 174 findings · 18 reviews · Skin
No studies found 53 · 30.5%GRADE not reported 13 · 7.5%Very low 23 · 13.2%Low 41 · 23.6%Moderate 34 · 19.5%High 10 · 5.7%
Minoxidil 2% vs minoxidil 5%
Adverse events · women with FPHL
Minoxidil 2% showed no clear difference in adverse events compared with minoxidil 5% (low certainty).
1 finding from 1 review
- RR 1.02 [0.91, 1.2]4 studies · 1006 participantsLow
Minoxidil 2% vs minoxidil 5%
Proportion of participants with investigator‐rated clinically significant hair regrowth · women with FPHL
1 finding from 1 review
- no estimate extracted3 studies · 586 participantsModerate
Minoxidil 2% vs minoxidil 5%
Change from baseline to study conclusion in total hair count · women with FPHL
1 finding from 1 review
- no estimate extracted3 studies · 631 participantsLow
Minoxidil 2% vs minoxidil 5%
Degree of hair shedding from baseline to the end of the study · women with FPHL
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Minoxidil 2% vs minoxidil 5%
Cosmetic appearance of the hair or participant satisfaction · women with FPHL
1 finding from 1 review
- no estimate extracted2 studies · 322 participantsModerate
Minoxidil 2% vs minoxidil 5%
Change in quality (or pattern) of hair regrowth (e.g. thickness) · women with FPHL
1 finding from 1 review
- no estimate extracted2 studies · 322 participantsModerate
Minoxidil 2% vs minoxidil 5%
Proportion of participants with self‐rated clinically significant hair regrowth · women with FPHL
1 finding from 1 review
- no estimate extracted2 studies · 322 participantsLow
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Proportion of participants with adverse event · Participants with rosacea
Minocycline 45 mg showed no clear difference in proportion of participants with adverse event compared with minocycline 45 mg + azelaic acid gel (low certainty).
1 finding from 1 review
- RR 0.69 [0.39, 1.22]1 study · 60 participantsLow
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Physician‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 60 participantsLow
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Assessment of erythema or telangiectasia · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 60 participantsLow
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Lesion count · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 60 participantsLow
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Time needed until improvement · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 60 participantsLow
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
NB‐UVB plus retinoid vs PUVA plus retinoid
Participant‐rated global improvement · People with chronic plaque or guttate psoriasis
1 finding from 1 review
- Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
NB‐UVB plus retinoid vs PUVA plus retinoid
Percentage of participants reaching PASI 75 · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in percentage of participants reaching PASI 75 compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
- Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes onlyRR 0.89 [0.59, 1.35]1 study · 60 participantsLow
NB‐UVB plus retinoid vs PUVA plus retinoid
Withdrawals due to adverse events · People with chronic plaque or guttate psoriasis
1 finding from 1 review
- Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
NB‐UVB plus retinoid vs PUVA plus retinoid
Clearance rate · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in clearance rate compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
- Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes onlyRR 0.93 [0.79, 1.1]2 studies · 90 participantsLow